Abilify Ingestible-Sensor Pill Seeks To Revolutionize Adherence

Otsuka and Proteus are seeking to revolutionize the adherence of medicines with their drug-device product, which embeds an ingestible sensor into the atypical antipsychotic Abilify (aripiprazole).

More from Neurological

More from Therapy Areas